{
    "clinical_study": {
        "@rank": "104049", 
        "acronym": "SPORT", 
        "arm_group": {
            "arm_group_label": "Single Pre-Operative Radiation Therapy", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if partial breast irradiation administered in a\n      single preoperative fraction is tolerable."
        }, 
        "brief_title": "Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer", 
        "completion_date": {
            "#text": "May 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Female aged 60 years or older.\n\n          -  Invasive ductal carcinoma.\n\n          -  Unifocal disease.\n\n          -  Tumors less than 2cm.\n\n          -  No clinical evidence of nodal disease.\n\n          -  Estrogen receptor status (ER) positive.\n\n          -  Her2 negative.\n\n        Exclusion Criteria:\n\n          -  Age less than 60 years.\n\n          -  BRCA 1 and/or BRCA 2 mutation.\n\n          -  Tumour histology limited to lobular carcinoma only.\n\n          -  Neoadjuvant hormonal manipulation or chemotherapy.\n\n          -  More than one primary tumour in different quadrants of the same breast.\n\n          -  Inability to view tumor on imaging."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01717261", 
            "org_study_id": "12030"
        }, 
        "intervention": {
            "arm_group_label": "Single Pre-Operative Radiation Therapy", 
            "description": "Dose escalation: 3 patients will receive 15 Gy in a single fraction. The following 3 patients will receive 18 Gy. The final 4 patients will receive 20 Gy.", 
            "intervention_name": "Single Pre-Operative Radiation Therapy", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "breast cancer", 
            "early breast cancer", 
            "partial breast irradiation", 
            "preoperative radiation"
        ], 
        "lastchanged_date": "October 26, 2012", 
        "location": {
            "contact": {
                "email": "lroyhuneault.hmr@ssss.gouv.qc.ca", 
                "last_name": "Linda Roy-Huneault", 
                "phone": "5142523425"
            }, 
            "facility": {
                "address": {
                    "city": "Montreal", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "H1T 2M4"
                }, 
                "name": "Maisonneuve-Rosemont Hospital"
            }, 
            "investigator": {
                "last_name": "Michael Yassa, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "other_outcome": {
            "measure": "Ipsilateral breast cancer recurrence", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "overall_contact": {
            "email": "myassa.hmr@ssss.gouv.qc.ca", 
            "last_name": "Michael Yassa, MD", 
            "phone": "15142523425"
        }, 
        "overall_official": {
            "affiliation": "Maisonneuve-Rosemon Hospital", 
            "last_name": "Michael Yassa, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Assess acute toxicity and wound healing complications from the preoperative radiation treatment as per NCI CTCAE Common Toxicity Scale.", 
            "measure": "Acute toxicity", 
            "safety_issue": "Yes", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01717261"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Maisonneuve-Rosemont Hospital", 
            "investigator_full_name": "Michael Yassa", 
            "investigator_title": "Radiation Oncologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Assess late-onset toxicity associated with a single fraction radiation treatement as per RTOG/EORTC Late Radiation Toxicity Scale", 
                "measure": "Chronic toxicity", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Cosmesis will be evaluated as per the EORTC Breast Cancer Cosmetic Rating scale.", 
                "measure": "Cosmetic outcome", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "source": "Maisonneuve-Rosemont Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Maisonneuve-Rosemont Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}